ArticleNeurology and therapy2026

Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis.

Ning Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.